Arterial Remodeling Technologies S.A.

In recent years, drug-coated balloon catheters (DCBs) have emerged as one of the fastest growing segments of the peripheral artery disease (PAD) market, driven by an aging population, improving reimbu

The cardiology sector has long been one of the most innovative in medtech, with technologies such as drug-eluting stents (DES) and transcatheter aortic valves cutting down the need for more invasive o

Abbott Laboratories Inc. ’s Absorb everolimus-eluting bioresorbable vascular scaffold( BVS ) remains on track for a late-2015 PMA submission based on data showing the novel device performed at lea

Tough times call for creativity. The contraction of the number of venture firms and a significant decrease in the quantity of funds available for investing in medtech mean that entrepreneurs and ventu